Pharmacokinetics of 5-aminosalicylic acid from controlled-release capsules in man
暂无分享,去创建一个
S. Weir | D. Giesing | D. K. Yu | R. Lanman | B. Morrill | L. Eichmeier | M. B. Lanman
[1] D. Giesing,et al. Effect of food coadministration on 5‐aminosalicylic acid oral suspension bioavailability , 1990, Clinical pharmacology and therapeutics.
[2] S. Hansen,et al. New metabolites of the drug 5-aminosalicylic acid. I: N-beta-D-glucopyranosyl-5-aminosalicylic acid. , 1989, Xenobiotica; the fate of foreign compounds in biological systems.
[3] M. Peppercorn. Sulfasalazine: Pharmacology, Clinical Use, Toxicity, and Related New Drug Development , 1984 .
[4] K. Das,et al. Sulfasalazine. Adverse effects and desensitization. , 1983, Digestive diseases and sciences.
[5] E. Hudson,et al. Sulphasalazine and male infertility: reversibility and possible mechanism. , 1981, Gut.
[6] H. Mekhjian,et al. National Cooperative Crohn's Disease Study: adverse reactions to study drugs. , 1979, Gastroenterology.
[7] K. Das,et al. Clinical Pharmacokinetics of Sulphasalazine , 1976, Clinical pharmacokinetics.